Clinical Trial Update: NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for NY-ESO-1 plasmid DNA cancer vaccine pPJV7611 in multiple cancers with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Esophageal Cancer
• Non-small Cell Lung Cancer
• Prostate Cancer
• Sarcoma

Drugs mentioned

• NY-ESO-1 plasmid DNA (pPJV7611) cancer vaccine (NY-ESO-1 plasmid DNA cancer vaccine pPJV7611)

Snippet

Sponsor: Ludwig Institute for Cancer Research | Conditions: Prostate Cancer, Bladder Cancer | Phase 1 | Status: COMPLETED | Results posted: 2021-10-08